Smoking Cessation for Patients With Acute Coronary Syndrome (ACS)
PATPAC
Effectiveness of a Managed Care Smoking Cessation Program in Patients With Acute Coronary Syndrome Based on Nicotine Replacement as a Treatment and a Cognitive-behavioral Approach
3 other identifiers
interventional
144
1 country
1
Brief Summary
The aim of the present study is to assess if a personal care program of smokers hospitalised for acute coronary syndrome can change the smoking habits as compared with similar patients in conventional care program at 6 months. The program includes a cognitive-behavioural approach associated with a nicotine replacement treatment presented as an obligatory non optional treatment. Patients are men and women of less than 70 years old hospitalised for acute coronary syndrome. Major exclusion criteria is the presence of another dependence. The program includes a cognitive-behavioural approach based on the specific technique of "exposure" and the prescription of nicotine patch considered as other usual cardiologic treatments for at least 6 months. The end point is the smoking habits at 6 months classified as: no smoking confirmed by CO measurement, smoking or doubtful (declaration of no smoking by the patient but a CO level \> 10 ppm). 72 patients in each group will be included in 2 majors sites.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 30, 2009
CompletedFirst Posted
Study publicly available on registry
October 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2010
CompletedDecember 26, 2016
November 1, 2013
1.1 years
September 30, 2009
December 23, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The smoking habits at 6 months classified as : no smoking confirmed by CO measurement, smoking or doubtful (declaration of no smoking by the patient but a CO level > 10 ppm).
6 month
Secondary Outcomes (1)
Assessment depending of age classes, sex, anxiety scale and other psychological characteristics
6 month
Study Arms (2)
cognitive behavioural approach
EXPERIMENTALspecific technique of cigarette exposure and nicotinic treatment adjustment
usual approach
ACTIVE COMPARATORrecommendations and nicotinic substitutes
Interventions
Nicotine replacement
Eligibility Criteria
You may qualify if:
- Patients are men and women of less than 70 years old
- Hospitalised for acute coronary syndrome in cardiology Intensive Care Unit
- Active smoking \>5 cigarettes/day
- Has given consent to participate in the study and haven't expressed its opposition the exploitation of data as part of the study
You may not qualify if:
- Presence of another dependence : alcohol abuse avowed or strongly suspected, addiction to drugs, high dose benzodiazepine dependence. clinical assessment
- Major psychiatric disorders or history. clinical assessment
- Treatment with lithium and neuroleptic. clinical assessment
- Patient whose cardiac problem could lead to hemodynamic instability during 48 h after admission.
- Patient scheduled for programmed hospitalisation within 6 months after release from hospital (\>3 days long, including coronary bypass)
- Patients presenting another severe pathology requiring 6 months specific treatments. clinical assessment
- Patient which cannot understand or read French
- Patient with possible side-effect to nicotine substitute
- Patient unaffiliated to any social security regime
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assistance Publique - Hôpitaux de Parislead
- Ministry of Health, Francecollaborator
- National Cancer Institute, Francecollaborator
Study Sites (1)
CHU Lariboisière, APHP, Cardiology
Paris, Île-de-France Region, 75010, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick HENRY, MD,PhD
Assistance Publique - Hôpitaux de Paris
- STUDY DIRECTOR
Laurent MAGNE
Cabinet MAGNE & GALLY
- STUDY DIRECTOR
Olivia GALLY
Cabinet MAGNE & GALLY
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2009
First Posted
October 1, 2009
Study Start
September 1, 2008
Primary Completion
October 1, 2009
Study Completion
April 1, 2010
Last Updated
December 26, 2016
Record last verified: 2013-11